emlenoflast   Click here for help

GtoPdb Ligand ID: 12172

Synonyms: Inzomelid | MCC-7840 | MCC7840
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Emlenoflast (MCC7840 [2]; formerly IZD 174) is one of a growing number of NLRP3 inflammasome inhibitors that have been developed for anti-inflammatory potential [3]. It was developed by Inflazome (acquired by Roche in 2020) as an orally bioavailable drug that is able to cross the blood-brain barrier.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 101.47
Molecular weight 388.16
XLogP 3.6
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(NS(=O)(=O)c1ccn(n1)C(C)C)Nc1c2CCCc2cc2c1CCC2
Isomeric SMILES CC(C)n1ccc(n1)S(=O)(=O)NC(=O)Nc1c2CCCc2cc2c1CCC2
InChI InChI=1S/C19H24N4O3S/c1-12(2)23-10-9-17(21-23)27(25,26)22-19(24)20-18-15-7-3-5-13(15)11-14-6-4-8-16(14)18/h9-12H,3-8H2,1-2H3,(H2,20,22,24)
InChI Key MTOUOUSKXWSTAX-UHFFFAOYSA-N
Bioactivity Comments
Emlenoflast (MCC7840) inhibits activation of NLRP3-containing inflammasomes, but its precise binding mechanism has not been reported.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
NLRP3 Hs Inhibitor Inhibition 6.8 pIC50 - 1
pIC50 6.8 (IC50 1.42x10-7 M) [1]
Description: Measuring inhibition of IL-1β production by LPS primed, ATP-activated human primary microglial cells